Condition: Lymphatic Obstruction · Sponsor: University of Pennsylvania
The project will be performed over a period of approximately two years. In the first year the \[18F\]FTHA tracer will be developed, optimized, and tested on normal volunteers. During the second year, the tracer will be investigated on patients with suspected obstruction of the thoracic duct (TD).
This description comes directly from the study's public registry record.
Erin K Schubert, BA · 2155736569 · erin.schubert@pennmedicine.upenn.edu
Mary Hansbury, BS · 215-746-8192 · mary.hansbury@pennmedicine.upenn.edu
Always discuss trial participation with your own doctor first.
| University of Pennsylvania Hospital | Philadelphia, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07645573